Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes.

Source: Carral, F., et al. (2015). - Pubmed ID: 25629547

Setting: Spain, University hospital

Study design:

CT –pro


Follow up: NA

Patient group:

Sample size:

Total: 104 (93)

IG: 40 (38)

CG: 64 (55)


Inclusion criteria:

  • Age over 18 years
  • Diabetes before or during pregnancy
Type of technology:

Website (‘diabetic’)

  • Data transfer
  • Monitoring
  • Messaging

Email or phone

  • Feedback on data

Intervention: Glucose control was evaluated every 2 weeks on a Web-based telemedicine system called ‘‘DiabeTIC’’ with feedback by email or phone message. Furthermore in clinic evaluation at the diabetes unit every 6–8 weeks. All patients were reevaluated in a face-to-face visit between 6 to 12 weeks after delivery.


Duration: NA
Add on: –

Control group:
Glucose was evaluated every 2 or 3 weeks until delivery at a diabetes unit.

Clinical effect/ Patient safety:

Clinical effect:

  • HbA1c →
  • Insulin therapy ↓
  • Cesarean delivery →

Patient safety: NA

Patient experiences/ Staff experiences:

Patient experiences: NA

Staff experiences: NA

Costs and organization:



  • Bloodglucose monitor

Staff resources

  • Development of website


Staff resources

  • Monitoring patients
  • Messaging patients

Organization:  NA

Health care utilization:

  • Diabetes unit visits ↓
  • Nurse educator visits ↓
  • GP visits ↓
Scroll to Top


“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)